销售模式、定价模式及市场行情、同行业可比公司情况，说明国内销售毛利率 与海外毛利率差异原因，报告期相关收入同比变化原因及合理性。请年审会计 师发表意见。 公司回复 证券代码：603059 证券简称：倍加洁 公告编号：2025-034 倍加洁集团股份有限公司 关于 2024 年年度报告信息披露监管问询函的 回复公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 倍加洁集团股份有限公司（以下简称"公司"或"倍加洁"）于近日收到上 海证券交易所上市公司管理一部下发的《关于倍加洁集团股份有限公司 2024 年 年度报告的信息披露监管问询函》（上证公函【2025】0852 号）（以下简称"《问 询函》"）。根据《问询函》的要求，公司与立信会计师事务所（特殊普通合伙） （以下简称"年审会计师"）、上海科东资产评估有限公司（以下简称"评估机构"） 就《问询函》提及的事项逐项进行了认真核查与落实，现将《问询函》所涉及问 题回复如下： 在《问询函》相关问题的回复中，若合计数与各分项数值相加之和在尾数上 存在差异，均为四舍五入所致。如无特别说明 ...

Core Viewpoint - The company, Beijia Clean (倍加洁), announced a share reduction plan by its shareholders due to funding needs, which may impact the stock's performance in the market [1] Shareholder Reduction Plan - Shareholders Nanjing Xiaobei No.1 and Nanjing Xiaobei No.2 plan to reduce their holdings through block trading, with Xiaobei No.1 intending to sell up to 1,250,000 shares (approximately 1.2444% of total shares) and Xiaobei No.2 up to 750,000 shares (approximately 0.7466% of total shares) [1] - The reduction will occur within three months after the announcement, with a limit of 2% of total shares in any consecutive 90-day period [1] Shareholder Background - The shareholders involved are employee stock ownership platforms, with the actual controller Zhang Wensheng also serving as the executive partner of both Xiaobei No.1 and Xiaobei No.2, indicating a unified action relationship among them [2] - As of the announcement date, Xiaobei No.1 holds 6,875,000 shares (6.8443% of total shares) and Xiaobei No.2 holds 4,125,000 shares (4.1066% of total shares) [1][2] Financial Performance - For the year 2024, the company reported a revenue of 1.299 billion yuan, a year-on-year increase of 21.78%, while the net profit attributable to shareholders was a loss of 77.32 million yuan, compared to a profit of 92.51 million yuan in the previous year [4][5] - The net cash flow from operating activities decreased by 10.10% to 139.04 million yuan [4][5] - In Q1 2025, the company achieved a revenue of 324 million yuan, a year-on-year increase of 13.28%, but the net profit attributable to shareholders decreased by 34.48% to 12.41 million yuan [4][5]

Summary of Key Points Core Viewpoint - The announcement details a share reduction plan by major shareholders of Beijiajie Group Co., Ltd., indicating a need for liquidity and outlining the specifics of the planned share sales [1][2]. Shareholder Information - The shareholders involved in the reduction are employee stock ownership platforms, specifically Nanjing Xiaobei No. 1 and Nanjing Xiaobei No. 2, which hold shares acquired before the company's IPO and through capital reserve increases [2][3]. Reduction Plan Details - Nanjing Xiaobei No. 1 plans to reduce up to 1,250,000 shares, representing no more than 1.2444% of the total share capital, while Nanjing Xiaobei No. 2 intends to reduce up to 750,000 shares, accounting for no more than 0.7466% of the total share capital [2][4]. - The reduction will occur through block trading within three months starting from 15 trading days after the announcement, with a cap of 2% of total shares in any 90-day period [2][5]. Shareholder Background - Nanjing Xiaobei No. 1 holds 6,875,000 shares (6.8443% of total), while Nanjing Xiaobei No. 2 holds 4,125,000 shares (4.1066% of total) [3][4]. - Both shareholders are identified as having a unified action relationship due to their common control by Zhang Wensheng, the actual controller of the company [4][5]. Compliance and Commitments - The reduction plan complies with relevant laws and regulations, including the Securities Law of the People's Republic of China and the Shanghai Stock Exchange rules [6][7]. - Shareholders have made commitments regarding the holding period and conditions under which shares may be sold, ensuring that the reduction does not affect the company's governance structure or ongoing operations [5][6].

重要内容提示： 股东持股的基本情况 2025 年 5 月 28 日，倍加洁集团股份有限公司（以下简称"公司"或"发行 人"）披露《关于股东变更名称、经营范围、主要经营场所暨完成工商变更登记 的公告》（公告编号：2025-031），公司股东扬州竟成企业管理咨询合伙企业（有 限合伙）的名称变更为南京小倍一号企业管理咨询合伙企业（有限合伙）（以下 简称"小倍一号"）；股东扬州和成企业管理咨询合伙企业（有限合伙）的名称变 更为南京小倍二号企业管理咨询合伙企业（有限合伙）（以下简称"小倍二号"）。 上述股东系公司员工持股平台。 截至本公告披露日，公司股东小倍一号、小倍二号分别持有公司股份 6,875,000 股、4,125,000 股，分别占公司总股本的 6.8443%、4.1066%。上述股 份均来源于公司首次公开发行前持有的股份及上市后以资本公积金转增股本方 式取得的股份，均为无限售条件流通股。 证券代码：603059 证券简称：倍加洁 公告编号：2025-032 倍加洁集团股份有限公司 股东大宗交易减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其 ...

证券代码：603059 证券简称：倍加洁 公告编号：2025-033 倍加洁集团股份有限公司 关于控股子公司住所变更并换发营业执照的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 倍加洁集团股份有限公司控股子公司善恩康生物科技（苏州）有限公司（以 下简称"善恩康"）因业务经营发展需要，进行住所变更。善恩康的住所由"昆 山市张浦镇三家路 388 号"变更为"江苏省苏州市昆山市张浦镇德望路 261 号 8 层 9 层"。 善恩康现已办理完成工商变更登记手续，并取得了昆山市数据局换发的营业 执照，除住所变更外，善恩康营业执照其他登记事项未发生改变，变更后的登记 信息如下： 法定代表人：张文生 注册资本：8729.2808 万元整 成立日期：2016 年 09 月 29 日 住所：江苏省苏州市昆山市张浦镇德望路 261 号 8 层 9 层 经营范围：从事生物科技领域内的技术咨询、技术转让、技术服务、技术开 发；食品及食品添加剂的研发、生产；其他食品、饮料（固体饮料）、糖果的生 产（按《食品生产许可证》核定项目经营）；家用电器、电 ...

Core Viewpoint - The company Beijiajie (603059.SH) announced a plan for shareholders to reduce their holdings by a total of 1.99% of the company's shares through block trading due to funding needs [1] Summary by Relevant Sections Shareholder Reduction Plan - Shareholders Xiaobei No.1 and Xiaobei No.2 plan to reduce their holdings by up to 1.25 million shares (1.2444% of total share capital) and 750,000 shares (0.7466% of total share capital) respectively [1] Timing and Conditions - The reduction period is set from July 17, 2025, to October 16, 2025 [1] - The two shareholders are part of the company's employee stock ownership plan and have a concerted action relationship with the actual controller Zhang Wensheng [1] Market Uncertainty - The reduction plan may be subject to uncertainties due to market conditions and the company's stock price [1]

倍加洁（603059）公告，公司股东小倍一号计划减持不超过125万股，占公司总股本的1.2444%；小倍 二号计划减持不超过75万股，占公司总股本的0.7466%。减持方式为大宗交易，减持期间为2025年7月 17日至2025年10月16日。减持原因是股东资金需求。本次减持计划不会对公司治理结构及持续经营情况 产生重大影响。 ...

Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative return of over 20% within the next six months [6][18]. Core Views - The company is focusing on expanding its product categories internally while also pursuing external growth through acquisitions. The performance in 2024 is expected to be impacted by fluctuations in the operations of its associate company, Weimeizi, and underperformance from its subsidiary, Shanenkang, leading to impairment provisions for long-term equity investments and goodwill [1][5]. - The company has a significant production capacity for toothbrushes and wet wipes, and it is actively expanding its toothpaste category, with production capacity increasing from 60 million to 120 million units [3]. Financial Performance Summary - In Q1 2025, the company achieved revenue of 320 million yuan, a year-on-year increase of 13.3%, but the net profit attributable to the parent company was 10 million yuan, a decline of 34.5% year-on-year [1]. - For the full year 2024, the company reported revenue of 1.3 billion yuan, up 21.8% year-on-year, but a net loss of 80 million yuan, a significant decline of 183.6% year-on-year [1][10]. - The gross margin for 2024 was 23.9%, an increase of 0.7 percentage points year-on-year, with specific margins for oral care and wet wipes being 22.6% and 23.5%, respectively [2][11]. Product Segment Summary - In 2024, toothbrush revenue was 500 million yuan, an increase of 8.5% year-on-year, with sales volume reaching 420 million units, a rise of 14.7%. The average price per unit decreased by 5.5% to 1.19 yuan [1]. - Wet wipes generated revenue of 390 million yuan, up 15.3% year-on-year, with sales volume of 5.28 billion pieces, an increase of 19.0%, while the average price per unit decreased by 4.0% to 0.07 yuan [1]. Strategic Initiatives - The company is enhancing its support for its subsidiary, Shanenkang, focusing on developing major customer relationships and implementing performance evaluation mechanisms to improve its financial performance [4]. - The company is also prioritizing the development of its own brand products alongside its ODM business, aiming for scale growth in toothpaste, toothbrushes, and orthodontic care products while ensuring reasonable profit margins [3].

Core Viewpoint - The company reported a significant increase in revenue for 2024 but faced a net loss due to underperformance in its subsidiaries and impairment provisions [1][2]. Financial Performance - In 2024, the company achieved a revenue of 1.299 billion yuan, a year-on-year increase of 21.78%, but reported a net loss of 77.3161 million yuan, reversing from profit [1]. - For Q1 2025, the company generated a revenue of 324 million yuan, a year-on-year growth of 13.28%, while the net profit was 12.4105 million yuan, down 34.48% compared to the previous year [1]. Subsidiary Performance - The net profit decline in Q1 2025 was primarily attributed to increased losses from the associate company, Weimei Zi, which is currently in a loss position [2]. - Conversely, the subsidiary, Shan'en Kang, achieved a turnaround to profitability in the same quarter [2]. Product Margins - The gross margin for toothbrushes in Q1 2025 was 25.52%, an increase of 1.79 percentage points compared to 2024, while the gross margin for wet wipes was 23.14%, a decrease of 0.4 percentage points [2]. Brand Development Strategy - The company plans to focus its proprietary brand business on three main categories: toothpaste, toothbrushes, and orthodontic oral care products, aiming for scale development while ensuring reasonable profits [2]. - In Q1 2025, the proprietary brand business generated revenue of 27.74 million yuan, a year-on-year increase of 22%, accounting for 8% of total revenue [2]. Overseas Business - In 2024, the overseas business generated revenue of 784 million yuan, representing approximately 60.35% of total revenue [3]. - The company is in the process of establishing a production base in Vietnam, primarily for wet wipes and toothbrushes, with plans for factory renovation already determined [3].

Group 1: BOE Technology Group (京东方A) - The LCD industry supply and demand situation is improving, shifting focus from scale and market share competition to high-profit applications, high-value products, advanced technology, and high-value brands [1] - By Q1 2025, the average operating rate of the LCD industry is expected to gradually increase and maintain above 80% [1] - LCD TV panel prices have been rising since January 2025, with expectations of a gradual cooling in Q2 [1] - The company’s 8.6-generation MOLED production line in Chengdu has started equipment installation four months ahead of schedule [1] - In 2024, the IT segment is projected to account for the highest share of the company’s display device business revenue at 34% [1] - The company anticipates depreciation of approximately 38 billion in 2024, expecting to reach a peak this year [1] - The company is open to industry consolidation and will consider multiple factors for participation [1] Group 2: Haixiang New Materials (海象新材) - The company has not yet launched PET flooring products and has no related revenue; PET flooring will coexist with PVC flooring rather than completely replace it [2] - The revenue growth relies on stable sales in non-US regions, recovery in the US market, and expansion in the domestic market [2] - The company has taken measures to mitigate the impact of customs traceability issues [2] - The impact of US tariffs is minimal, as the company has established production capacity in Southeast Asia [2] - There are currently no plans to set up a factory in the US in the short term [2] Group 3: Beijia Clean (倍加洁) - In 2024, the production capacity utilization rate for toothbrushes is 57.68%, while for wet wipes it is 28.98% [3] - The annual production capacity for toothpaste is expected to increase to 120 million units, with new clients such as Comfort and Shuke [3] - The company focuses on its own brands in toothpaste, toothbrushes, and orthodontic oral care products, with a comprehensive layout on e-commerce platforms [3] - The ODM business is the main focus, with moderate investment in self-owned brands [3] - The US market accounts for 24% of total revenue, with some small clients canceling orders; the company is responding through its Vietnam base [3] - The associate company, Weimei Zi, is projected to have a net profit of 32.96 million in 2024, with a loss in Q1 2025 [3] - The controlling subsidiary, Shan'en Kang, is expected to incur losses in 2024 but aims to turn profitable in Q1 2025, focusing on major client development and the KK bacteria niche market [3] - The company aims for double-digit revenue growth in 2025, with the Vietnam production base project still under construction [3] Group 4: ICBC Credit Suisse Asset Management (工银瑞信基金) - As of now, the total asset management scale of the company is 778.131 billion, ranking 13th out of 210 [4] - The asset management scale for non-monetary public funds is 422.31 billion, also ranking 13th out of 210 [4] - The company manages 474 public funds, ranking 12th out of 210 [4] - There are 85 fund managers under the company, ranking 10th out of 210 [4] - The best-performing public fund product in the past year is the ICBC North Securities 50 Index A, with a latest net value of 1.54 and a growth of 66.21% in the past year [4] - The latest public fund product raised by the company is the ICBC Stable and Profitable 120-Day Rolling Bond A, which is a long-term bond type with a subscription period from May 6, 2025, to May 28, 2025 [4]